Distinguished Speaker Faculty

 


Philip M. Arlen, M.D., President & CEO, Precision Biologics, Inc.
Aadra Bhatt, Ph.D., Post-Doctoral Fellow, Chemistry, University of North Carolina at Chapel Hill
Adrian Bot, M.D., Ph.D., Vice President, Translational Sciences, Kite Pharma
Shrish Budree, M.D., Senior Clinical Research Fellow, Clinical Research, Openbiome
Stephen Cary, Ph.D., Co-Founder & CEO, Omniox
Zhao Chen, Ph.D., Investigator III, Exploratory Immuno-Oncology, Novartis Institute of Biomedical Research
Sungyoo Cho, Ph.D., CSO, Green Cross LabCell
Rodolphe Clerval, Chief Business Officer, Vice President US Operations, Enterome Bioscience
Ezra Cohen, M.D., Associate Director, Moores Cancer Center, Professor of Medicine, University of California San Diego
Julia Drewes, Ph.D., Post-Doctoral Fellow, Oncology, Johns Hopkins School of Medicine, Bloomberg Kimmel Institute for
Rohit Duggal, Ph.D., Senior Director, Cellular Therapy – TNK, Sorrento Therapeutics
Mark Exley, Ph.D., Vice President, Agenus
Alan L. Epstein, M.D., Ph.D., Professor, Pathology, Keck School of Medicine, University of Southern California
Elizabeth Evans, Ph.D., Vice President, Preclinical Research, Vaccinex
Dean W. Felsher, M.D., Ph.D., Director, Translational Research and Applied Medicine, Oncology Research, Stanford University School of Medicine
Agnete Fredriksen, Ph.D., CSO, Vaccibody
Kelsey Gauthier, Ph.D., Scientist, Aduro BioTech
Vancheswaran Gopalakrishnan, Ph.D., Post-Doctoral Fellow, Surgical Oncology, University of Texas MD Anderson Cancer Center
Jeremy R. Graff, Ph.D., CSO and Senior Vice President, Research, Biothera Pharmaceuticals, Inc.
Matthew M. Gubin, Ph.D., Instructor, Schreiber Lab, Pathology and Immunology, Washington University School of Medicine
James R. Heath, Professor of Physics, Chemistry, California Institute of Technology
Ramy Ibrahim, M.D., VP, Clinical Development, Parker Institute for Cancer Immunotherapy
Lata Jayaraman, Ph.D., Head, Tumor Immunotherapy, Seres Therapeutics
Shawn Jensen, Ph.D., Senior Scientist, Molecular and Tumor Immunology, Robert W Franz Cancer Research Center
Suchit Jhunjhunwala, Ph.D., Scientist, Bioinformatics & Computational Biology, Genentech
Karin Joos, Ph.D., CSO, Gritstone Oncology
Sune Justesen, CSO, Immunitrack
Dan Kaufman, M.D., Ph.D., Professor, Director of Cell Therapy Program, University of California, San Diego
Sanjay Khare, Ph.D., President, ImmunGene
Suresh Kumar, Ph.D., Senior Director, R&D, Progenra, Inc.
Hans Klingemann, M.D., Ph.D., Vice President, Research & Development, NantKwest, Inc.
Jane Lebkowski, Ph.D., President, R&D and CSO, Asterias
Holger Lode, Ph.D., Professor and Chair of Pediatrics, Pediatric Hematology and Oncology, University Medicine Greifswald
Manuel Maia, M.D., Fellow, Medical Oncology, City of Hope
Arpita Maiti, PhD, Senior Director, External Science & Innovation, Inflammation & Immunology and Microbiome, Pfizer Inc.
Pranab Mukherjee, MSc, Ph.D., Associate Professor, Dermatology, Case Western Reserve University
Patrick Ott, M.D., Dana-Farber Cancer Institute
Alex Karlsson-Parra, M.D., Ph.D., CSO, Immunicum
Sandip Patel, M.D., Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics, Thoracic Oncology; Assistant Director, Clinical Trials Office, Medicine/Hematology & Oncology, University of California, San Diego Moores Cancer Center
Laszlo Radvanyi, Ph.D., Senior Vice President, Senior Scientific Advisor, Immunology, Immuno-Oncology, EMD Serono
Osama Rahma, M.D., Assistant Professor, Medicine, Center for Immuno-Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School
Svetlana Sadekova, Ph.D., Senior Principal Scientist, Head of Translational Pathology Group, Merck
Michael R. Shurin, M.D., Ph.D., Professor, Pathology, Immunology, University of Pittsburgh Medical Center
David F. Stroncek, M.D., Chief, Cell Therapy Section, Transfusion Medicine, NIH Clinical Center
Jan Spanholtz, Ph.D., CSO, Glycostem
Martin Treder, Ph.D., CSO, R&D, Affimed
Bahram (Bob) Valamehr, Ph.D., MBA, Vice President, Cancer Immunotherapy, Fate Therapeutics, Inc.
Anita Y Voigt, Ph.D., Post-Doctoral Researcher, The Jackson Laboratory for Genomic Medicine
Danny Wells, Ph.D., Scientist, Informatics, Parker Institute for Cancer Immunotherapy
David Wustrow, Vice President, Drug Discovery, FLX Bio, Inc.
Theresa Zhang, Ph.D., Vice President, Personalized Cancer Vaccines, Genocea
Bin Zheng, Ph.D., Assistant Professor, Dermatology, Harvard Medical School, Massachusetts General Hospital
Wei Zhou, Ph.D., Post-Doctoral Research Associate, The Jackson Laboratory for Genomic Medicine